Symptom severity of bipolar disorder during the menopausal transition

被引:25
|
作者
Marsh W.K. [1 ]
Gershenson B. [2 ]
Rothschild A.J. [3 ]
机构
[1] Department of Psychiatry, School of Medicine, University of Massachusetts, 55 Lake Ave North, S3-314, Worcester, 01655, MA
[2] Department of Orthopedics and Physical Rehabilitation, University of Massachusetts, 55 Lave Ave N - AC7 069, Worcester, MA
[3] Department of Psychiatry, University of Massachusetts, 55 Lave Ave North, Worcester, MA
基金
美国国家卫生研究院;
关键词
Bipolar disorder; Estrogen; Menopause; Neuroendocrinology;
D O I
10.1186/s40345-015-0035-z
中图分类号
学科分类号
摘要
Background: Little is known about the mood symptom experience of women with bipolar disorder during the menopausal transition (MT). Yet times of rapid hormonal decline, such as the postpartum, are associated with increased risk of severe mood episodes in bipolar disorder, and the MT is a time of increased risk for unipolar depression in women with or without a history of depression. Methods: Enrollment included 56 women 40–60 years old diagnosed in the bipolar spectrum who were experiencing menopausal symptoms or were up to 5 years since their final menstrual period. Menopausal stages included early menopause, late menopause, or early postmenopause based on standardized criteria. Observational, prospective standardized mood symptom and reproductive hormone assessments were completed periodically. Concurrent menopausal symptoms as well as history of mood exacerbation during past reproductive events were assessed. Results: Forty-four women were included in the main analysis. The average Montgomery-Asberg Depression Rating Scale (MADRS) score was 4.43 points higher in the late transition/early postmenopausal stage women (n = 29) compared to the early menopausal stage women (n = 15) (±SE 2.14; p = 0.039), corresponding to a roughly 10 % higher score (range 0–40) in the late/post stage across all study visits. Results were similar for the Young Mania Rating Scale (YMRS), where the average score was 2.54 points higher in the late/early postmenopausal stage women compared to the early menopausal stage women (±SE 1.15; p = 0.027), also roughly 10 % higher (range 0–26). Estradiol and follicle-stimulating hormone (FSH) absolute levels as well as between-visit change in levels were not notably associated with YMRS or MADRS during study observation. Total Greene Climacteric Symptom (menopausal symptom) score was significantly associated with MADRS but not YMRS. History of mood exacerbation premenstrually and/or postpartum was not significantly associated with YMRS or MADRS severity during the MT. Conclusions: These results support the theory that times of increased reproductive hormonal changes, such as the late MT and early postmenopause, here compared to early MT, are associated with greater mood symptom severity in bipolar spectrum women. Nonetheless, absolute or change in FSH and estradiol levels were not significantly associated with depression or mood elevation severity. © 2015, Marsh et al.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder
    Mukherjee, Dahlia
    Krishnamurthy, Venkatesh Bassapa
    Millett, Caitlin E.
    Reider, Aubrey
    Can, Adem
    Groer, Maureen
    Fuchs, Dietmar
    Postolache, Teodor T.
    Saunders, Erika F. H.
    BIPOLAR DISORDERS, 2018, 20 (01) : 27 - 34
  • [22] The association of kynurenine pathway metabolites with symptom severity and clinical features of bipolar disorder: An overview
    Bartoli, Francesco
    Cioni, Riccardo M.
    Cavaleri, Daniele
    Callovini, Tommaso
    Crocamo, Cristina
    Misiak, Blazej
    Savitz, Jonathan B.
    Carra, Giuseppe
    EUROPEAN PSYCHIATRY, 2022, 65 (01)
  • [23] Symptom experience during menopausal transition: Low income Korean immigrant women
    Im, EO
    Meleis, AI
    Lee, KA
    WOMEN & HEALTH, 1999, 29 (02) : 53 - 67
  • [24] Effects of mind-body therapies on symptom clusters during the menopausal transition
    Woods, N. F.
    Mitchell, E. S.
    Schnall, J. G.
    Cray, L.
    Ismail, R.
    Taylor-Swanson, L.
    Thomas, A.
    CLIMACTERIC, 2014, 17 (01) : 10 - 22
  • [25] Development of the Brief Bipolar Disorder Symptom Scale for patients with bipolar disorder
    Dennehy, EB
    Suppes, T
    Crismon, ML
    Toprac, M
    Carmody, TJ
    Rush, AJ
    PSYCHIATRY RESEARCH, 2004, 127 (1-2) : 137 - 145
  • [26] Correlation between depression/anxiety symptom severity and quality of life in patients with major depressive disorder or bipolar disorder
    Gao Keming
    Su Meilei
    Sweet, Jennifer
    Calabrese, Joseph R.
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 244 : 9 - 15
  • [27] Hypersexuality in bipolar disorder: an overlooked symptom
    Dolman, Clare
    Howard, Louise
    Goodwin, Guy M.
    Young, Allan
    Jones, Ian R.
    Bergink, Veerle
    Richardson, Thomas
    Di Florio, Arianna
    LANCET PSYCHIATRY, 2024, 11 (06): : 405 - 406
  • [28] Heightened inflammation in bipolar disorder occurs independent of symptom severity and is explained by body mass index
    Knight, Erik L.
    Engeland, Christopher G.
    Yocum, Anastasia K.
    Abu-Mohammad, Ahmad
    Bertram, Holli
    Vest, Erica
    Mcinnis, Melvin G.
    Saunders, Erika F. H.
    BRAIN, BEHAVIOR, & IMMUNITY - HEALTH, 2023, 29
  • [29] Psychotic Symptoms are Selectively Associated with Mood Symptom Severity and Worse Outcome in Pediatric Bipolar Disorder
    Bachman, Peter
    Merranko, John
    Tello, Itziar Baltasar
    Axelson, David
    Golstein, Benjamin
    Strober, Michael
    Gill, Mary Kay
    Hunt, Jeffrey
    Iyengar, Satish
    Ryan, Neal
    Keller, Martin
    Birmaher, Boris
    EARLY INTERVENTION IN PSYCHIATRY, 2018, 12 : 109 - 109
  • [30] Bipolar Disorder Comorbidity in Anxiety Disorders: Relationship to demographic profile, symptom severity, and functional impairment
    Fracalanza, Katie A.
    McCabe, Randi E.
    Taylor, Valerie H.
    Antony, Martin M.
    EUROPEAN JOURNAL OF PSYCHIATRY, 2011, 25 (04): : 223 - 233